News

Latest news

Hide mandatory notifications of trade

Ex-date in Subsequent offering in Nutri Pharma ASA

01.02.2010 - Reference is made to the stock exchange release dated today regarding Nutri Pharma ASA ("the Company") successfully raising NOK 100 million in a contemplated Private Placement

This information is subject of the disclosure
requirements acc. to §5-12 in the Norwegian
Securities Act.

Reference is made to the stock exchange release dated
today regarding Nutri Pharma ASA ("the Company")
successfully raising NOK 100 million in a
contemplated Private Placement, as well as a
potential subsequent repair offering 
(the "Subsequent Offering"). The Subsequent Offering
will consist of up to 10 million shares at a
subscription price equal to the subscription price in
the Private Placement, i.e. NOK 2.00 per share,
directed at shareholders of the Company as of 29
January, as registered in the VPS in the morning of 4
February 2010. The shares in Nutri Pharma ASA will
trade without the right to participate in the
potential Subsequent Offering from and including
today 1 February 2010 ("ex-date"). The Subsequent
Offering in the Company is expected to take place as
soon as a prospectus for such offering has been
approved by the Oslo Stock Exchange, and subsequent
to the issue of the Private Placement shares;
anticipated soon after 18 February. The Subsequent
Offering is conditional upon corporate approvals,
including for completion of the Private Placement.
Details about the Subsequent Offering will be
announced later.

This release does not entail a public offering to
subscribe for shares. The shares to be offered in the
contemplated offering have not been and will not be
registered under the U.S. Securities Act of  1933, as
amended (the`U.S. Securities Act`), or any state
securities laws. The offering  may be restricted with
respect to persons and shareholders within the United
States and certain other countries.